Solid Biosciences, Inc. (SLDB)
6.395
-0.54
(-7.72%)
USD |
NASDAQ |
Feb 11, 16:00
6.46
+0.06
(+1.02%)
After-Hours: 17:35
Solid Biosciences Total Liabilities (Quarterly) : 55.97M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 655.02M |
| Sarepta Therapeutics, Inc. | 2.173B |
| Plus Therapeutics, Inc. | 13.62M |
| BioStem Technologies, Inc. | 12.38M |
| Iovance Biotherapeutics, Inc. | 202.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 273.91M |
| Shareholders Equity (Quarterly) | 217.95M |
| Debt to Equity Ratio | 0.1007 |
| Current Ratio | 6.737 |
| Net Debt Paydown Yield | 0.14% |